Accueil › Cancer du sein › Connecticut › Bridgeport
Essais cliniques pour Cancer du sein à Bridgeport, CT
21 études pour Cancer du sein recherchent des participants dans et autour de Bridgeport (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Stony Brook University Medical Center, Stony Brook · à 18 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Recrutement en coursPhase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · à 18 mi
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Recrutement en coursPhase 3
- Research Site, Stony Brook · à 18 mi
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Recrutement en coursPhase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · à 4 mi
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · à 5 mi
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutement en cours
- Stony Brook Cancer Center, Stony Brook · à 18 mi
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Recrutement en coursPhase 1/2
- Stony Brook University Hospital, Stony Brook · à 18 mi
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Recrutement en coursPhase 3
- Stony Brook University Medical Center, Stony Brook · à 18 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recrutement en coursPhase 3
- Stony Brook University Cancer Center, Stony Brook · à 18 mi
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recrutement en coursPhase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · à 19 mi
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · à 19 mi
- New York Cancers & Blood Specialists, Port Jefferson Station · à 19 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Recrutement en coursPhase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · à 4 mi
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · à 5 mi
- et 1 autres
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Recrutement en coursPhase 2
- Stony Brook Cancer Center, Stony Brook · à 18 mi
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Recrutement en coursPhase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · à 4 mi
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · à 5 mi
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Recrutement en coursPhase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · à 19 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Recrutement en coursPhase 3
- Stony Brook University Cancer Center, Stony Brook · à 18 mi
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Recrutement en coursPhase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · à 5 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Recrutement en coursPhase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · à 4 mi
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · à 5 mi
- Stony Brook University Medical Center, Stony Brook · à 18 mi
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Recrutement en coursÉtude observationnelle
- Stony Brook Medicine, Stony Brook · à 18 mi
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Recrutement en coursPhase 1 précoce
- Stony Brook Breast Center, Stony Brook · à 18 mi
Definitive Radiation Therapy for Inoperable Breast Cancer
Recrutement en cours
- Stony Brook University Cancer Center, Stony Brook · à 18 mi
Definitive Radiation for High-Risk Spine Metastases
Recrutement en coursPhase 2
- Stony Brook University Hospital, Stony Brook · à 18 mi
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Recrutement en coursÉtude observationnelle
- Stony Brook University Cancer Center, Stony Brook · à 18 mi
Essais pour Cancer du sein dans d'autres villes
- New York City, NY136 études
- Houston, TX126 études
- Boston, MA112 études
- Nashville, TN81 études
- Los Angeles, CA73 études
- Edison, NJ68 études
- St. Louis, MO64 études
- Queens, NY64 études
- Durham, NC64 études
- Chicago, IL59 études
- Philadelphia, PA56 études
- Dallas, TX55 études
Autres études à Bridgeport
- Cancer du poumon non à petites cellules14 études
- Cancer du poumon13 études
- Leucémie aiguë myéloïde12 études
- Maladie cardiovasculaire9 études
- Cancer (tous types)8 études
- Carcinome épidermoïde de la tête et du cou8 études
- Cancer métastatique7 études
- Insuffisance cardiaque7 études
- Anévrisme cérébral6 études
- Myélome multiple6 études
- Cancer de la prostate6 études
- Cancer de l'ovaire5 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.